Challenges in Commercializing Companion Diagnostics
Challenges in Commercializing Companion Diagnostics Overcoming Key Barriers in the Commercialization of Companion Diagnostics Introduction: The Growing Need for CDx Commercial Strategies As precision medicine advances, companion diagnostics (CDx) have become integral to ensuring the safe and effective use of targeted therapies. However, developing a validated assay is only part of the journey—commercializing a CDx…
Read More “Challenges in Commercializing Companion Diagnostics” »